PAOLA FORTI

Prof. Dr. PAOLA FORTI

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 March 2010 in Journal of the American Geriatrics Society
Verified
Journal Article
Closed access
PDF file
PFPAOLA FORTI
PAOLA FORTI
NPNicoletta Pisacane
Nicoletta Pisacane
ERElisa Rietti
Elisa Rietti
ALAnna Lucicesare
Anna Lucicesare
VOValentina Olivelli
Valentina Olivelli
GRGiovanni Ravaglia
Giovanni Ravaglia

1 January 2013 in Neurology
Verified
Journal Article
Closed access
PDF file
PFPAOLA FORTI
PAOLA FORTI
FMFabiola Maioli
Fabiola Maioli
GPGaetano Procaccianti
Gaetano Procaccianti
VNValeria Nativio
Valeria Nativio
MLMaria-Vittoria Lega
Maria-Vittoria Lega
TSTommaso Sacquegna
Tommaso Sacquegna
Objective: Incidence of ischemic stroke (IS) increases with age. Knowledge of factors associated with IS acute outcomes in the oldest-old (≥80 years) is needed to improve quality of care and resource allocation in this age group. Methods: Data are for 769 consecutive IS patients aged ≥60 years (436 aged ≥80 years) admitted to an Italian stroke unit in a 4-year period. Demographics, prestroke disability (modified Rankin Scale ≥3) and comorbidities, IS etiology and subtype, NIH Stroke Scale (NIHSS) score, clinical and laboratory admission parameters, and medical complications were prospectively registered. Independent predictors of in-hospital death, incident disability, length of stay, discharge without rehabilitation, and no direct discharge home were identified by multiple logistic regression. Risk profiles before and after age 80 were compared. Results: Poor outcomes were more frequent in the oldest-old compared to the younger patients. NIHSS score, clinical parameters of IS severity (need for oxygen, indwelling catheter, or nasogastric tube), incident disability, and medical complications predicted most of the study outcomes in both age groups. After age 80, IS etiology and subtype proved additional independent determinants for most outcomes along with age, sex, and prestroke functional and health status. Conclusions: Characteristics related to neurologic impairment on admission were the main predictors of acute outcomes of IS in this cohort. Specific IS etiology and subtype influenced IS outcomes only after age 80. In oldest-old patients, demographics and prestroke functional and health status also influenced IS outcomes with peculiar associations.

1 January 2012 in Archives of Gerontology and Geriatrics
Verified
Journal Article
Closed access
PFPAOLA FORTI
PAOLA FORTI
ERElisa Rietti
Elisa Rietti
NPNicoletta Pisacane
Nicoletta Pisacane
VOValentina Olivelli
Valentina Olivelli
BMBenedetta Maltoni
Benedetta Maltoni
GRGiovanni Ravaglia
Giovanni Ravaglia

11 August 2020 in GeroScience
Verified
Journal Article
Open access
PDF file
AMAntonio Muscari
Antonio Muscari
GBGiampaolo Bianchi
Giampaolo Bianchi
PFPAOLA FORTI
PAOLA FORTI
DMDonatella Magalotti
Donatella Magalotti
PPPaolo Pandolfi
Paolo Pandolfi
TGThe Pianoro Study Group
The Pianoro Study Group
NT-proB-type natriuretic peptide (NT-proBNP) increases with age and is associated with all-cause mortality. With this study, we assessed its possible utilization as a marker of biological age in comparison with other variables. The study included 1079 non-institutionalized elderly subjects (mean age 72.8 ± 5.5 years, 561 women). Baseline measurements were performed of serum NT-proBNP and of some laboratory variables previously utilized to estimate biological age (creatinine, albumin, C-reactive protein, cholesterol, blood glucose, leukocytes, lymphocytes, hemoglobin, mean cell volume). During 7 years of follow-up, 114 all-cause deaths occurred. The logarithm of NT-proBNP was the most age-related parameter (r = 0.35, P < 0.0001). Its relationship with mortality, according to Cox regression and ROC curve (AUC = 0.707, 95% CI 0.654–0.759), was stronger than that of all other variables, including age. In multivariate analysis, only NT-proBNP and age remained independently associated with mortality. The regression lines between age and NT-proBNP (pg/ml) allowed a separate estimation of biological age (“proBNPage”) for men (= [log(NT-proBNP) + 1.2068]/0.0827) and for women (= [log(NT-proBNP) − 1.5258]/0.0478). The hazard ratio of all-cause mortality for the fifth quintile of proBNP age (≥ 85 years) compared with the first quintile (< 61 years) was 7.9 (95% CI 3.6–17.5). Similarly, the difference between pro-BNPage and chronological age was associated with a hazard ratio of 3.5 in the fifth quintile (95% CI 1.9–6.4) and was associated with disease count (P for trend = 0.0002). In conclusion, NT-proBNP was the best indicator of biological age, which can be estimated by simple formulas and might be used for prognostic purposes or as a surrogate end point in epidemiological and intervention studies.

23 March 2011 in Gerontology
Verified
Journal Article
Closed access
PFPAOLA FORTI
PAOLA FORTI
VOValentina Olivelli
Valentina Olivelli
ERElisa Rietti
Elisa Rietti
BMBenedetta Maltoni
Benedetta Maltoni
GPGianluca Pirazzoli
Gianluca Pirazzoli
GRGiovanni Ravaglia
Giovanni Ravaglia
Background: It is unclear whether in late life serum thyroid-stimulating hormone (TSH) predicts risk of developing cognitive impairment. Objective: This study investigated the prospective relationship of serum TSH with the risk of developing mild cognitive impairment (MCI), Alzheimer’s disease (AD) and vascular dementia (VaD) in an elderly cohort with a 4-year follow-up. Methods: Data are for 660 subjects aged 65 years and older from an Italian population-based cohort who were cognitively normal at an extensive assessment in 1999/2000 and underwent follow-up assessment in 2003/2004. Serum TSH was measured at baseline. Multinomial logistic models adjusted for sociodemographic and cardiovascular risk factors were used to investigate the association of serum TSH (both as a tertile and continuous log-transformed variable) with risk of incident MCI, AD and VaD diagnosed according to international criteria. Results: Over 3.8 ± 0.7 years of follow-up, there were 149 incident MCI cases (77 with impairment of memory and 72 with impairment of nonmemory domains) and 86 incident dementia cases (53 with AD, 28 with VaD). No association between baseline TSH and risk of developing any MCI subtype or AD was found. The highest TSH tertile had a threefold higher increased risk of VaD (OR: 3.25, 95% CI: 1.01–10.77, p = 0.048) compared to the lowest tertile. Risk of VaD increased about 60% for each 1 SD increase in log-transformed TSH (OR: 1.61, 95% CI: 1.06–2.44, p = 0.025). Conclusions: In this elderly cohort, baseline TSH was not related to the risk of developing MCI or AD, but high TSH was associated with an increased risk of VaD. These results suggest further need for research using larger samples to examine the role of TSH as a predictor of VaD and the role of thyroid autoimmunity in vascular cognitive impairment.

20 April 2012 in European Journal of Clinical Investigation
Verified
Journal Article
Closed access
PDF file
PFPAOLA FORTI
PAOLA FORTI
GPGian L. Pirazzoli
Gian L. Pirazzoli
BMBenedetta Maltoni
Benedetta Maltoni
GBGiampaolo Bianchi
Giampaolo Bianchi
DMDonatella Magalotti
Donatella Magalotti
MZMarco Zoli
Marco Zoli